These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29470486)

  • 1. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.
    Mateer EJ; Huang C; Shehu NY; Paessler S
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection.
    Yun NE; Ronca S; Tamura A; Koma T; Seregin AV; Dineley KT; Miller M; Cook R; Shimizu N; Walker AG; Smith JN; Fair JN; Wauquier N; Bockarie B; Khan SH; Makishima T; Paessler S
    J Virol; 2015 Dec; 90(6):2920-7. PubMed ID: 26719273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques.
    Cashman KA; Wilkinson ER; Zeng X; Cardile AP; Facemire PR; Bell TM; Bearss JJ; Shaia CI; Schmaljohn CS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current small animal models for LASV hearing loss.
    Sattler RA; Maruyama J; Shehu NY; Makishima T; Paessler S
    Curr Opin Virol; 2019 Aug; 37():118-122. PubMed ID: 31479989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset sensorineural hearing loss in Lassa fever.
    Ibekwe TS; Okokhere PO; Asogun D; Blackie FF; Nwegbu MM; Wahab KW; Omilabu SA; Akpede GO
    Eur Arch Otorhinolaryngol; 2011 Feb; 268(2):197-201. PubMed ID: 20809263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of Lassa Fever and Its Disease Management in West Africa.
    Reyna RA; Littlefield KE; Shehu N; Makishima T; Maruyama J; Paessler S
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
    Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK;
    PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lassa Fever Induced Hearing Loss: The Neglected Disability of Hemorrhagic Fever.
    Ficenec SC; Percak J; Arguello S; Bays A; Goba A; Gbakie M; Shaffer JG; Emmett SD; Schieffelin JS; Bausch D
    Int J Infect Dis; 2020 Nov; 100():82-87. PubMed ID: 32795603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for animal models for Lassa fever vaccine development.
    Lukashevich IS
    Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers.
    Brisse M; Fernández-Alarcón C; Huang Q; Kirk N; Schleiss MR; Liang Y; Ly H
    Virulence; 2022 Dec; 13(1):1049-1061. PubMed ID: 35758052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Common CD8
    Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.
    Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF
    Virol J; 2011 Aug; 8():404. PubMed ID: 21843352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
    Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
    Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N Guinea pigs.
    Huynh T; Gary JM; Welch SR; Coleman-McCray J; Harmon JR; Kainulainen MH; Bollweg BC; Ritter JM; Shieh WJ; Nichol ST; Zaki SR; Spiropoulou CF; Spengler JR
    Antiviral Res; 2020 Nov; 183():104928. PubMed ID: 32898586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-onset paraparesis in Lassa fever: A case report.
    Duvignaud A; Doutchi M; Abejegah C; Etafo I; Jaspard M; Serra B; Tricaud E; Levy-Marchal C; Anglaret X; Ahmed LA; Adedosu AN; Malvy D; Ayodeji OO
    Int J Infect Dis; 2020 Mar; 92():49-52. PubMed ID: 31866549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced vaccine candidates for Lassa fever.
    Lukashevich IS
    Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The niche of One Health approaches in Lassa fever surveillance and control.
    Arruda LB; Haider N; Olayemi A; Simons D; Ehichioya D; Yinka-Ogunleye A; Ansumana R; Thomason MJ; Asogun D; Ihekweazu C; Fichet-Calvet E; Kock RA
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):29. PubMed ID: 33894784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
    Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
    Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.